[Testicular tumors: our follow-up and treatment protocol. Report of 30 cases].
The high incidence of testicular tumors seen in our setting prompted us to review our therapeutic and follow-up protocols and assess patient survival and course within the period spanning June, 1989 to August, 1992. During this 38-month period, we diagnosed a total of 30 cases (15 seminoma, 2 pure embryonal carcinoma, 8 mixed embryonal, 3 lymphoma and 2 Leydig cell tumors). Apart from orchidectomy, we utilized radiotherapy, chemotherapy and resection of residual tumor mass, according to the histological type and tumor stage. Of the 15 seminomas, there was 1 death (6%), 9 cases (60%) are tumor free with a mean survival of 25 months, and 5 cases (34%) are in partial remission at 11.3 months mean follow-up. Of the 10 nonseminomatous tumors, there was 1 death (10%), 5 patients (50%) are in complete remission at 23.6 months (mean), 3 (30%) are in partial remission at 19.3 months (mean) and 1 (10%) is in frank progression as manifested by the unresectable masses of the retroperitoneal lymph nodes. The survival rate for the seminoma group was 94% and 90% for the nonseminomatous tumors.
Lozano Ortega
J L
JL
Servicio de Urología, Hospital de Cruces, Bilbao, Vizcaya, España.
Llarena Ibarguren
R
R
Pertusa Peña
C
C
D000328:Adult; D000368:Aged; D002985:Clinical Protocols; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D015996:Survival Rate; D013736:Testicular Neoplasms / Q000401:mortality / Q000628:therapy*
Tumores testiculares: nuestra pauta de seguimiento y tratamiento. A propósito de 30 casos.